Category Archive for: "Blog"

Patience is a necessity for small biotech investors via @FT https://t.co/Sq88U0bLXL — The Propell Group (@ThePropellGroup) August 11, 2018

Artificial Intelligence for Drug Discovery Landscape Overview Q2 / 2018 Industry Analysis https://t.co/TFIRopRzKD — The Propell Group (@ThePropellGroup) August 10, 2018

A simple artificial heart could permanently replace a failing human one https://t.co/1WF71EeTyq — The Propell Group (@ThePropellGroup) August 9, 2018

Shares in Novo Nordisk fall after warning on US price cuts via @FT https://t.co/w4WXYRaEBG — The Propell Group (@ThePropellGroup) August 8, 2018

Jennifer Doudna: ‘I still remember my first encounter with DNA’ https://t.co/e5pPKNDyrM — The Propell Group (@ThePropellGroup) August 8, 2018

Carl Icahn targets ‘ridiculous’ Cigna takeover of Express Scripts via @FT https://t.co/SLiaOBcJPg — The Propell Group (@ThePropellGroup) August 7, 2018

Identity crisis: the insurers moving away from insurance via @FT https://t.co/UWPNDGSh6B — The Propell Group (@ThePropellGroup) August 7, 2018

Grab’s latest play is to become lender and insurer to Southeast Asia’s ‘middle economy’ https://t.co/3b26iEgKV9 — The Propell Group (@ThePropellGroup) August 7, 2018

China private equity funds suffer wave of closures via @FT https://t.co/GWbZoaj8zD — The Propell Group (@ThePropellGroup) August 6, 2018

Private equity groups fear US clampdown on Chinese investors via @FT https://t.co/pynWaDaBrc — The Propell Group (@ThePropellGroup) August 6, 2018